Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 20, Issue 10, Pages 3558-3567Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.20.10.3558-3567.2000
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL19242, P01 HL019242] Funding Source: Medline
- NIDDK NIH HHS [DK28312, R01 DK052753, R01 DK028312, DK52753, R01 DK052378] Funding Source: Medline
Ask authors/readers for more resources
Control of the translational repressor, PHAS-I, was investigated by expressing proteins with Ser/Thr--> Ala mutations in the five (S/T)P phosphorylation sites. Results of experiments with HEK293 cells reveal at least three levels of control. At one extreme is nonregulated phosphorylation, exemplified by constitutive phosphorylation of Ser82. At an intermediate level, amino acids and insulin stimulate the phosphorylation of Thr36, Thr45, and Thr69 via mTOR-dependent processes that function independently of other sites in PHAS-I. At the third level, the extent of phosphorylation of one site modulates the phosphorylation of another. This control is represented by Ser64 phosphorylation, which depends on the phosphorylation of all three TP sites. The five sites have different influences on the electrophoretic properties of PHAS-I and on the affinity of PHAS-I for eukaryotic initiation factor 4E (eIF4E). Phosphorylation of Thr45 or Ser64 results in the most dramatic decreases in eIF4E binding in vitro. However, each of the sites influences mRNA translation, either directly by modulating the binding affinity of PHAS-I and eIF4E or indirectly by affecting the phosphorylation of other sites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available